ORBIMED CAPITAL GP II LLC

Insider CIK 1281668 · XLRN · SUPN Director, 10% owner

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
XLRN ACCELERON PHARMA INC	C Conversion deriv	2013-09-24	2013-09-26	23,442	—	$0	0	SEC↗
XLRN ACCELERON PHARMA INC	C Conversion deriv	2013-09-24	2013-09-26	8,777	—	$0	0	SEC↗
XLRN ACCELERON PHARMA INC	C Conversion deriv	2013-09-24	2013-09-26	83,097	—	$0	0	SEC↗
XLRN ACCELERON PHARMA INC	C Conversion deriv	2013-09-24	2013-09-26	31,113	—	$0	0	SEC↗
XLRN ACCELERON PHARMA INC	C Conversion deriv	2013-09-24	2013-09-26	22,612	—	$0	0	SEC↗
XLRN ACCELERON PHARMA INC	C Conversion deriv	2013-09-24	2013-09-26	8,466	—	$0	0	SEC↗
XLRN ACCELERON PHARMA INC	C Conversion deriv	2013-09-24	2013-09-26	38,924	—	$0	0	SEC↗
XLRN ACCELERON PHARMA INC	C Conversion deriv	2013-09-24	2013-09-26	65,680	—	$0	0	SEC↗
XLRN ACCELERON PHARMA INC	C Conversion deriv	2013-09-24	2013-09-26	175,419	—	$0	0	SEC↗
XLRN ACCELERON PHARMA INC	C Conversion deriv	2013-09-24	2013-09-26	422,101	—	$0	0	SEC↗
XLRN ACCELERON PHARMA INC	C Conversion deriv	2013-09-24	2013-09-26	1,127,346	—	$0	0	SEC↗
XLRN ACCELERON PHARMA INC	C Conversion deriv	2013-09-24	2013-09-26	14,574	—	$0	0	SEC↗
XLRN ACCELERON PHARMA INC	C Conversion	2013-09-24	2013-09-26	175,419	—	$0	1,308,590	SEC↗
XLRN ACCELERON PHARMA INC	C Conversion	2013-09-24	2013-09-26	422,101	—	$0	424,282	SEC↗
XLRN ACCELERON PHARMA INC	C Conversion	2013-09-24	2013-09-26	38,924	—	$0	1,540,759	SEC↗
XLRN ACCELERON PHARMA INC	C Conversion	2013-09-24	2013-09-26	1,127,346	—	$0	1,133,171	SEC↗
XLRN ACCELERON PHARMA INC	C Conversion	2013-09-24	2013-09-26	14,574	—	$0	576,889	SEC↗
XLRN ACCELERON PHARMA INC	C Conversion	2013-09-24	2013-09-26	65,680	—	$0	489,962	SEC↗
XLRN ACCELERON PHARMA INC	C Conversion	2013-09-24	2013-09-26	13,431	—	$0	562,315	SEC↗
XLRN ACCELERON PHARMA INC	C Conversion	2013-09-24	2013-09-26	35,873	—	$0	1,501,835	SEC↗
XLRN ACCELERON PHARMA INC	C Conversion	2013-09-24	2013-09-26	50,145	—	$0	548,884	SEC↗
XLRN ACCELERON PHARMA INC	C Conversion	2013-09-24	2013-09-26	133,930	—	$0	1,465,962	SEC↗
XLRN ACCELERON PHARMA INC	C Conversion	2013-09-24	2013-09-26	8,777	—	$0	498,739	SEC↗
XLRN ACCELERON PHARMA INC	C Conversion	2013-09-24	2013-09-26	23,442	—	$0	1,332,032	SEC↗
SUPN SUPERNUS PHARMACEUTICALS I	S Sale	2013-02-13	2013-02-14	41,100	$7.58	$311.5K	817,000	SEC↗
SUPN SUPERNUS PHARMACEUTICALS I	S Sale	2013-02-13	2013-02-14	108,900	$7.58	$825.5K	2,183,000	SEC↗
SUPN SUPERNUS PHARMACEUTICALS I	S Sale	2013-02-12	2013-02-14	110,700	$7.52	$832.5K	2,291,900	SEC↗
SUPN SUPERNUS PHARMACEUTICALS I	S Sale	2013-02-12	2013-02-14	41,483	$7.52	$312.0K	858,100	SEC↗
SUPN SUPERNUS PHARMACEUTICALS I	S Sale	2012-12-18	2012-12-19	100,000	$7.08	$708.0K	0	SEC↗
SUPN SUPERNUS PHARMACEUTICALS I	S Sale	2012-12-17	2012-12-19	197,815	$6.85	$1.36M	100,000	SEC↗
SUPN SUPERNUS PHARMACEUTICALS I	C Conversion deriv	2012-05-04	2012-05-08	2,498,842	—	$0	0	SEC↗
SUPN SUPERNUS PHARMACEUTICALS I	C Conversion deriv	2012-05-04	2012-05-08	827,627	—	$0	0	SEC↗
SUPN SUPERNUS PHARMACEUTICALS I	C Conversion deriv	2012-05-04	2012-05-08	6,673,891	—	$0	0	SEC↗
SUPN SUPERNUS PHARMACEUTICALS I	C Conversion	2012-05-04	2012-05-08	206,816	—	$0	206,816	SEC↗
SUPN SUPERNUS PHARMACEUTICALS I	P Buy	2012-05-04	2012-05-08	274,873	$5.00	$1.37M	899,583	SEC↗
SUPN SUPERNUS PHARMACEUTICALS I	P Buy	2012-05-04	2012-05-08	734,128	$5.00	$3.67M	2,402,600	SEC↗
SUPN SUPERNUS PHARMACEUTICALS I	P Buy	2012-05-04	2012-05-08	90,999	$5.00	$455.0K	297,815	SEC↗
SUPN SUPERNUS PHARMACEUTICALS I	C Conversion	2012-05-04	2012-05-08	624,710	—	$0	624,710	SEC↗
SUPN SUPERNUS PHARMACEUTICALS I	C Conversion	2012-05-04	2012-05-08	1,668,472	—	$0	1,668,472	SEC↗